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Most infants with long-gap esophageal atresia receive an esophageal replacement with tissue from stomach or colon, because the
nativeesophagusistooshortfortrueprimaryrepair.Tissue-engineeredesophagealconductscouldpresentanattractivealternative.
In this paper, circular decellularized porcine esophageal scaﬀold tissues were implanted subcutaneously into Sprague-Dawley rats.
Depending on scaﬀold cross-linking with genipin, glutaraldehyde, and carbodiimide (untreated scaﬀolds : positive control; bovine
pericardium : gold standard), the number of inﬁltrating ﬁbroblasts, lymphocytes, macrophages, giant cells, and capillaries was
determined to quantify the host response after 1, 9, and 30 days. Decellularized esophagus scaﬀolds were shown to maintain native
matrix morphology and extracellular matrix composition. Typical inﬂammatory reactions were observed in all implants; however,
the cellular inﬁltration was reduced in the genipin group. We conclude that genipin is the most eﬃcient and best tolerated cross-
linking agent to attenuate inﬂammation and to improve the integration of esophageal scaﬀolds into its surrounding tissue after
implantation.
1.Introduction
Pediatric tissue engineering is subjected to special require-
ments: the scaﬀolds need to be suitable for and adapted to
mechanical and biological changes during childhood [1].
As recently described, diﬀerent types of scaﬀold materials
such as hydrogels, synthetic, or natural scaﬀolds have already
been studied in tissue engineering, for example, long-gap
esophageal atresia [2–5]. In general, natural scaﬀolds possess
several advantages compared to other models. Decellularized
extracellular matrix (ECM) scaﬀolds can easily be obtained
from donors (humans or animals). All cellular components
can be removed from the scaﬀolds by the use of chemical,
biological, or mechanical methods and allowing an oﬀ-the-
shelf production [6]. ECM scaﬀolds are rich in structural
proteins and have an intact three-dimensional structure
[7]. By removing cells and cellular antigens, the ECM
scaﬀolds are obviously biocompatible and are thought not to
provoke a chronic rejection reaction after implantation into
another species. However, ECM proteins can also provide
costimulatory signals to immune cells [7–12]. Therefore,
inﬂammatory reactions and remodeling and degradation
processes cannot be excluded. The degree of inﬂammation
or remodeling is strongly dependent on the scaﬀold material
and chemical treatment, so-called cross-linking [6, 7, 13–
16]. It is supposed that native scaﬀolds are subjected to
fast enzymatic degradation in the recipient’s body, accom-
panied by the loss of mechanical properties. On the one
hand, degradation is necessary for the development of a
constructive remodeling process. However, on the other
hand,afterscaﬀoldimplantationinvivo,itneedstomaintain
its mechanical properties and the scaﬀold should be used
as a matrix for reseeding by diﬀerent tissue-typical cells.
After successful in-growth by, for example, muscle cells2 Journal of Biomedicine and Biotechnology
or ﬁbroblasts, remodeling processes in the scaﬀold will
occur according to the new biological environment (e.g.,
the subcutaneous region). A compromise has to be eﬀected
to lower the rate of degradation (without completely block-
ing), downregulate inﬂammation, and to increase the rate
of cellular inﬁltration. Both depend strongly on the bio-
logical properties of the scaﬀold. A common approach for
increasing the mechanical strength, inhibiting inﬂammatory
processes, and decreasing the rate of degradation of biologic
scaﬀolds is the use of chemical cross-linking agents.
The common principle of cross-linking is based on the
presumption that free amino (–NH2), carboxyl (–COOH),
and hydroxyl groups (–OH) on collagen may have antigenic
eﬀects. These free groups were cross-linked and masked
with appropriate chemical reagents such as glutaraldehyde,
genipin, or carbodiimides. Some cross-linking agents are
toxic (e.g., formalin) or tend to calciﬁcate the implant (e.g.,
glutaraldehyde (GA)); others have been described to be well
tolerated (e.g., genipin (GP)) or to be metabolized residue-
free in the cross-linking reaction (e.g., carbodiimide (CDI))
[17–19].
In the present study, we investigated in an animal model
whether an acellular esophagus provokes an inﬂamma-
tory response, rejection or is well tolerated. In detail, we
implanted small circular pieces of esophagus scaﬀolds into
rats subcutaneously. We used chemically pretreated (cross-
linked) and untreated scaﬀolds. Chemically pre-treated
scaﬀolds were cross-linked either with GA, GP, or CDI.
As control, commercially available bovine pericardium (BP;
St. Jude, USA; cross-linked with glutaraldehyde) was used.
Furthermore, the polarization of macrophages is important
to the remodeling outcome and was therefore investigated.
M1-activated macrophages express IL-12high,I L - 2 3 high,I L -
10low and produce inﬂammatory cytokines such as IL-1ß,
IL-6, and TNF-α, which promote active inﬂammation. They
are inducer and eﬀector cells in Th1-type inﬂammatory
responses [20] and express CCR7 as a surface cell marker [6,
21].Incontrast,M2-activatedmacrophageshaveanIL-12low,
IL-23low and IL10high phenotype and are able to facilitate
tissue repair and constructive remodeling [20, 22, 23].
M2 macrophages predominantly induce the Th2 response,
which is particularly beneﬁcial for the constructive tissue
remodeling. In addition, macrophages of anti-inﬂammatory
phenotype inhibit proinﬂammatory cytokines and express
the surface marker CD163 [15, 20, 24, 25]. Macrophages are
able to change their polarization in response to local stimuli
during the process of wound healing [26]. The recognition
of the predominant phenotype of macrophages provides
an indication of scaﬀold rejection, inﬂammation or accep-
tance after implantation. However, the anti-inﬂammatory
phenotype may be simultaneously detected with the gen-
eral macrophage marker CD68 by immunohistochemical
methods [27]. Furthermore, the general macrophage marker
CD68 also stains pro-inﬂammatory and not activated or
polarized macrophages. Therefore, the CD163/CD68 ratio
can be used to calculate the amount of M2 macrophages over
time.
Thus, the objective of this work was to characterize
the host response to diﬀerent cross-linked ECM esophageal
scaﬀolds, in particular aspects of inﬂammation or rejection
and the macrophage polarization to clarify the most suitable
cross-linking agent for the integration of ECM esophageal
scaﬀolds into its surrounding tissue after implantation.
2. Methods
2.1. Porcine Esophagus Scaﬀold. All experiments were per-
formed with esophagi of pigs (Deutsche Landrasse, 25–65kg)
in cooperation with the Heart Center Leipzig, Department
of Cardiac Surgery. The organs were obtained under sterile
conditions and stored at 4◦C in a 0.9% NaCl solution.
For decellularization, esophagi were cut into pieces of
8cm length, and the tunica adventitia was removed mechan-
ically. Esophagi were then placed in a 5% sodium dodecyl
sulfate-solution (SDS; Roth, Karlsruhe, Germany) for 7 days.
After complete removal of all cells, the scaﬀolds were washed
in phosphate buﬀered saline (PBS) for 2 days. After ﬁnishing
thedecellularization,thetissuewasdigestedenzymaticallyby
adding DNAse (200μg/mL; Sigma, Deisenhofen, Germany)
in PBS + MgCl2 (50mM) and incubated in 37◦Cf o r1 2h .
After washing in PBS, the scaﬀolds were sterilized by gamma
radiation (25 kGy from a 60Co source) and stored in PBS at
4◦C for maximum 4 weeks.
2.2. Histology. Following decellularization and after explan-
tation at day 1, 9, and 30 postimplantation, scaﬀolds were
ﬁxed in paraformaldehyde solution. Representative areas
were embedded in paraﬃn wax, cut into slices (5μm
thickness), and routinely stained by Azan and HE staining
[28]. In Azan stained slides, the matrix morphology of decel-
lularized porcine scaﬀolds was compared to that of native
esophagi using light microscopy. The assessment of HE-
stained neutrophils, ﬁbroblasts, giant cells, and microvessels
were performed by light microscopy on explanted scaﬀolds.
Cells were scored as follows: 0 = no cells; 1 = 1–100 cells; 2 ≥
100–200 cells; 3 ≥ 200 cells/5mm2.
2.3. Immunohistochemistry. Immunohistochemical analysis
of decellularized esophagus was performed with a commer-
cially available Envision DAB staining kit (DAKO, Carpinte-
ria, USA). Brieﬂy, formalin-ﬁxed, paraﬃn-embedded esoph-
agus tissue sections of 5μm thickness were deparaﬃnized.
Subsequently, slices were heated in 50mM Tris buﬀered
saline solution at 95◦C for 15min. After cooling, the slides
were incubated with proteinase K (250μg/mL) for 10min
and washed in distilled water. Endogenous enzyme activity
was blocked (10min, DAKO staining kit), and the tissue
slides were incubated with primary antibodies. The staining
steps with anti-collagen III (Acris Antibodies, Herford, Ger-
many), anti-collagen IV (Acris Antibodies), anti-ﬁbronectin
(Dianova, Berlin, Germany), and anti-elastin (Acris Anti-
bodies) were performed following the manufactures instruc-
tion (Envision DAB Staining Kit, DAKO). The speciﬁcity was
controlledbyomittingtheprimaryantibodies.Allantibodies
were diluted 1:100 in PBS. In stained slices, extracellular
matrixcompositionofdecellularizedandnativescaﬀoldswas
investigated by light microscopy.Journal of Biomedicine and Biotechnology 3
Table 1: Group composition with type and cross-linking of scaﬀolds.
Group n Type of scaﬀold Scaﬀold cross-linking
untreated 9 decellularized, sterilized esophagus scaﬀold untreated
GA 9 decellularized, sterilized esophagus scaﬀold glutaraldehyde
GP 9 decellularized, sterilized esophagus scaﬀold genipin
CDI 9 decellularized, sterilizedesophagus scaﬀold carbodiimide
BP (control) 9 decellularized, sterilized bovine pericard scaﬀold glutaraldehyde (bovine pericardium; St. Jude, USA)
sham (negative control) 15 — —
To investigate cellular inﬁltration in explanted scaﬀolds,
the following antibodies were used: anti-CD3, anti-CD68,
anti-CD163 (all Serotec, Oxford, UK), and anti-hydroxyl-
prolyl-hydrogenase (hPH, BMA Biomedical, Augst, Switzer-
land). All antibodies were diluted 1:50 in PBS. Control
experiments were carried out without primary antibodies.
To visualize the nuclei, all slices were counterstained with
Mayer’s hemalun solution. In stained slices, from each
section, the CD3, CD68, and CD163 positive cells as well
as nuclei were counted in 3 × 5 microscopic ﬁelds by
two blinded observers (magniﬁcation ×1000). The data are
represented as a ratio of CD-positive cells/nuclei (mean ±
standard error of mean (SEM)).
2.4. DNA Quantiﬁcation in Decellularized Matrix Scaﬀolds.
TheisolationandquantiﬁcationofDNAinthedecellularized
tissue scaﬀolds was performed using the protocol of Qiagen
(DNeasy, Hilden, Germany). In brief, decellularized esoph-
agus matrix scaﬀolds were cut into small cross-sectional
pieces of 25mg. Lysis buﬀer and proteinase K (Qiagen,
Hilden, Germany) were added, and samples were incubated
overnight in a shaking water bath (56◦C). After successful
tissue lysis, the DNA was puriﬁed and measured spectropho-
tometrically using a Nanodrop Spectrophotometer (Peqlab,
Erlangen, Germany). The DNA-content of matrix scaﬀolds
undergoing enzymatic digestion was compared to matrix
scaﬀolds without enzymatic digestion (both n = 6). Native
esophagus tissue served as positive control (n = 6).
2.5. Cross-Linking of Esophagus Scaﬀolds. For carbodiimide
cross-linking, circular pieces of esophagus scaﬀolds (3mm
thickness) were immersed in 2-(N-morpholino)eth-
anesulfonic acid buﬀer (MES buﬀer; 0.2M, pH 5.0; Sigma,
Munich, Germany). After 1h, the MES buﬀer was discarded
and the scaﬀolds were incubated in a solution consisting
of MES buﬀer (0.2M, pH 5.0), N-hydroxysuccinimide
(NHS; 0.12M), and N-(3-dimethylaminopropyl)-N-
ethylcarbodiimide (EDC; 0.3M). After 16h, the scaﬀolds
were removed and rinsed in MES buﬀer for 24h and in PBS
for at least 24h [17, 29]. For GP cross-linking, the scaﬀolds
were incubated in a 0.33% genipin/ethanol solution (Alexis,
Lausen, Switzerland) for 3 days at 37◦C. Then the scaﬀolds
were removed and rinsed in 75% ethanol for 2h and in PBS
for 3 days [21, 30, 31]. For glutaraldehyde cross-linking, the
scaﬀolds were immersed in 0.625% glutaraldehyde/distilled
water (Sigma) for 3 days at 37◦C. Subsequently, the scaﬀolds
were removed and washed in PBS for 3 days [32].
2.6. Subcutaneous Rat Model. 60 Sprague-Dawley rats were
grouped according to scaﬀold cross-linking: untreated, GA,
GP, CDI, BP, and sham group (each treatment group: n = 9;
sham group: n = 15; for details see Table 1). Each rat of the
treatmentgroups receiveda piece of scaﬀold subcutaneously.
Animals of the sham group underwent the same surgical
procedure but received no implants.
Before subcutaneous implantation of scaﬀolds, the an-
imals were anesthetized with 0.15mg/kg medetomidin
(Pﬁzer, Berlin, Germany), 2mg/kg midazolam (Ratiopharm,
Ulm, Germany), and 0.005mg/kg fentanyl (Janssen-Cilag,
Neuss, Germany). After 15min, circular pieces of cell-free
esophagus scaﬀolds (3mm thickness) were implanted into
a subcutaneous back pocket of the rat (1cm length). The
woundwassewnwithtwostitches.Finally,theanesthesiawas
antagonized with 0.75mg/kg atipamezol (Pﬁzer), 0.2mg/kg
ﬂumazenil (Roche, Penzberg, Germany), and 0.12mg/kg
naloxon (Ratiopharm). All surgical interventions were per-
formed under sterile conditions. For possible emerging
pain the rats were given carprofen (5mg/kg s.c, Pﬁzer)
postoperative for 3 days.
A f t e rp o s t o p e r a t i v ec a r ef o r1 ,9 ,a n d3 0d a y s ,t h ea n -
imals were narcotized, euthanized, and the scaﬀolds were
explanted. Tissue was immersed in 4% paraformaldehyde
s o l u t i o na n de m b e d d e di np a r a ﬃn for further histological
investigations (see above). All procedures were approved by
the committee of Animal Care and Use of the relevant local
governmental body (TVV03/09) in accordance to the law
of experimental animal protection. All eﬀorts were made to
minimize the number of animals used.
2.7. Statistics. The statistical evaluation of the immuno-
histology was performed by Kruskal-Wallis with post hoc
Mann-U-Whitney. Eﬀect of decellularization on the DNA-
content was evaluated using a one-way ANOVA, followed by
post hoc Tukey test for pairwise comparisons. Values of P<
0.05 were considered statistically signiﬁcant. Furthermore,
the lower and upper 95% conﬁdence intervals (CI) were
measured for the calculation of an area, where the true value
isofaprobabilityofatleast95%.Diﬀerenceswereconsidered
signiﬁcant if the lower and the upper CI among two groups
did not overlap.4 Journal of Biomedicine and Biotechnology
3. Results
3.1. Porcine Esophagus Scaﬀold. To investigate whether the
ECM composition of the decellularized esophagus scaf-
fold (Figure 1(a); top) is similar to native esophagus tis-
sue (Figure 1(a); bottom), both tissues were histologically
and immunohistologically characterized. Azan staining of
natural (Figure 1(b)) and acellular esophagus scaﬀolds
(Figure 1(c)) revealed anatomical intact structures, optimal
matrix geometry, and no remaining cellular structures. As
demonstrated in Figure 2, collagen III (Figure 2(a))a n d
ﬁbronectin(Figure 2(b))couldbeobservedinlargeamounts
in all tissue areas (submucosa, muscular layer) in acellular
similar to natural esophagi (small pictures, Figures 2(a)–
2(d)). The vessels expressed collagen IV (Figure 2(c))a n d
elastin, which is additionally located in tela submucosa
(Figure 2(d)).
3.2. DNA Quantiﬁcation. A one-way ANOVA revealed a sig-
niﬁcant eﬀect of decellularization on the DNA-content
compared to controls [F(2,15) = 15.918; P<0.001]. The
remaining DNA in the decellularized matrix scaﬀolds under-
going DNA digestion was 8.05 ± 2.01ng/mg versus 756.96 ±
49.07ng/mg in control tissues (native esophagus; n = 6).
The DNA content of decellularized matrix scaﬀolds without
nucleic acid digestion was 10.04 ± 3.01ng/mg (n = 6),
see Figure 3. The post hoc comparison did not reveal
signiﬁcant diﬀerences in the remaining DNA content of
decellularized scaﬀolds with and without DNA digestion
(P = 0.757). The percentage of remaining DNA content
afterbothprocedureswasdecreasedbyabout99%compared
with native esophagus tissue (P<0.001; without digestion:
98.7 ±0.4%, respectively, with digestion: 98.9 ±0.3%).
3.3. Response to Implanted Decellularized Esophagus Scaﬀolds.
A set of representative pictures of cell inﬁltration into
untreated (Figures 4(a)–4(c)) and cross-linked scaﬀolds
(GP, Figures 4(d)–4(f)) is shown in Figure 4.A td a y1
postimplantation,untreatedscaﬀolds(Figure 4(a))displayed
a cellular inﬁltration from the periphery to the center of
the tissue. In GP cross-linked scaﬀolds (Figure 4(d)), only
a cellular layer was detectable at the periphery. At day
9 postimplantation, an increase of inﬁltrating cells into
untreated scaﬀolds (Figure 4(b)) was observed compared to
GP cross-linked (Figure 4(e))s c a ﬀolds. At day 30 postim-
plantation, whole implants of the untreated scaﬀold group
(Figure 4(c)) were inﬁltrated with cells, whereas GP scaﬀolds
(Figure 4(f)) showed only an immaterial cellular inﬁltration.
Furthermore, in all cross-linked groups (GP, GA, CDI, BP)
the inﬁltrating rate was decreased compared to the untreated
scaﬀold group. Diﬀerences among GP, GA, CDI, and BP
could not be observed. In addition, untreated scaﬀolds were
degradedlargelycomparedtocross-linkedscaﬀoldsatday30
postimplantation. Furthermore, all scaﬀolds were inﬁltrated
with granulocytes migrating from the periphery to the
central region at day 1 postimplantation, without detecting
any diﬀerences among the groups. Single lymphocytes were
seen.
At day 9, the number of granulocytes decreased and ma-
crophages, ﬁbroblasts, and lymphocytes appeared. They also
migrated from the periphery to the center of the tissue. In
termsofchronic-granulatinginﬂammation,capillarygrowth
reached a maximum. Among the groups, no signiﬁcant
diﬀerences were detected.
At day 30, scaﬀolds were inﬁltrated by ﬁbroblasts and
sporadically by lymphocytes or granulocytes. In terms
of chronic-granulating inﬂammation, collagen ﬁbers and
macrophages were increased accompanied by decreased
amount of capillaries. All data are summarized in Figure 5.
For detailed analysis of inﬁltration of macrophages,
lymphocytes, and ﬁbroblasts, scaﬀold slides were stained
immunohistologically with anti-CD3, anti-CD68, anti-
CD163, and anti-hPH antibodies. For estimating the eﬀects,
the data of BP, GP, GA, and CDI were compared to those
of the untreated group. At day 1, no CD3-, CD163-, or
hPH-positive cells were detected in any scaﬀold. Scaﬀold
analysis at day 9 revealed a signiﬁcantly lower number of
CD163 macrophages in BP, whereas at day 30 in BP, GP, GA,
and CDI CD163 macrophages were signiﬁcantly decreased
as compared to the untreated group (Figure 6(a)). Also,
at day 9 only in the BP group CD68-positive cells were
observed to a signiﬁcantly lesser extent. However, at day 30,
CD68-positive cells were also signiﬁcantly decreased in the
GP group (Figure 6(b)). Additionally, in most groups the
amount of anti-inﬂammatory, proremodeling macrophage
M2 phenotype increased from day 9 to day 30, indicated
by a higher CD163/CD68 ratio (untreated: + 26.88%; BP: +
82.14%; GP: + 23.51%), except the GA (−28.65%) and CDI
(−74.79%) group (Figure 6(c)). Analysis of CD3-positive
lymphocytes reveals in all groups only a marginal inﬁltration
into the scaﬀold. The percentage was less than 0.5%, and no
signiﬁcantdiﬀerences between the groups were detected (not
shown). Immunohistological hPH staining demonstrated a
tendency to increase in number of ﬁbroblasts in the GA and
GP groups at day 9. At day 30, in the GP and CDI group, the
numbersofﬁbroblastsweresigniﬁcantlyincreasedcompared
to the untreated group (Figure 6(d)).
4. Discussion
Xenogenic biological ECM scaﬀolds are widely used in tissue
engineering for regenerative medicine. These scaﬀolds have
the advantage of possessing intact structural proteins and
growth factors that reduce inﬂammatory responses [33–36].
The response of the host to several xenogenic ECM scaﬀolds
has been well characterized and understood; however, it is
only partially studied in animal models for esophageal cross-
linked ECM scaﬀolds [7–13, 22, 24, 25, 35–41]. Additionally,
previously published data suggest that the host response
to the ECM scaﬀolds is strongly dependent on the species
and chemical pretreatment [15, 42]. Therefore, currently
published data are not universally valid.
Thus, it is essential to ﬁnd out the host response after
subcutaneous implantation of porcine esophagus scaﬀolds.
Furthermore, the outcome of the host response after implan-
tation of diﬀerent cross-linked ECM scaﬀolds was studied.Journal of Biomedicine and Biotechnology 5
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Figure 1: A representative piece of esophagus before (bottom) and after (top) decellularization (a). (b) and (c) show the tissue morphology
before (b) and after decellularization (c) of porcine esophagus. Acellular esophagus scaﬀolds showed anatomical intact structures, optimal
matrix geometry, and no remaining cellular structures. Connective tissue was stained blue, chromatin red, muscle cells orange, and
erythrocytes red. Magniﬁcation: ×40, bar = 100μm. Tmus: Tunica muscularis; Ts: Tela submucosa; Tmuc: Tunica mucosa.
Since the scaﬀolds were decellularized and morphologically
intact, we assume that a chronic rejection will not occur.
This is not common, because in studies with small intestinal
submucosa (SIS)-ECM T-lymphocyte inﬁltrations, encapsu-
lations and necrosis were observed as signs of rejection [13,
14]. In the present study, only in one animal, encapsulation
was observed at day 9 postimplantation. None of the used
scaﬀolds showed signs of necrosis or T-cell inﬁltration (CD3
≤ 0.5%).
Nevertheless, the implanted xenogenic esophagus scaf-
folds provoked inﬂammatory reactions. Signs of inﬂamma-
tion were granulocyte inﬁltration at day 1, encapsulation
by macrophages and ﬁbroblasts at day 9, and scaﬀold
inﬁltration of macrophages and ﬁbroblasts at day 30 postim-
plantation. This is characteristic for structural remodeling
processes such as scarring after foreign body implantation
and was consistent with our expectations. We do not assume
that DNA remnants of the scaﬀolds were the cause of
inﬂammatory reactions in our experiment, though in the
recent literature such a reaction was described. In most
biological material, remaining DNA consisted of fragments
less than 300bp. The remnant DNA is subject to fast
enzymatic degradation in vivo [15, 43] .I n s t e a do fr e m n a n t
DNA as cause of inﬂammation, it is more plausible that
free amino (–NH2), carboxyl (–COOH), and hydroxyl
(–OH) groups of the remaining collagen scaﬀold may be
responsible for the immunological reactions [18, 44]. To
avoid or inhibit such reactions, these free groups can be
bound byfunctionalgroupsofchemicalcross-linking, which
precludes the antigenic properties of collagen [17, 18, 45].
In the present study, the scaﬀolds were pretreated by three
diﬀerent cross-linking agents: CDI, GA, and GP. The cross-
linkers were selected in accordance with descriptions of the
biological compatibility in the recent literature [18, 34].
An alternative to the use of GA and GP may be the
application of CDI. First, CDI reacts with the free carboxyl-
followed by the amine groups of collagen, generating the
cross-link and representing a treatment method without
residual chemicals [17, 18]. By ﬁxation with CDI, tissue
quality was improved, the grade of calciﬁcation was lowered
(compared to GA), and no toxicity was observed [18].
CDI was also used as a cross-linking agent in commercially
available tissue products [15]. Nevertheless, in the present
study a ﬁxation of the esophagus scaﬀolds with CDI did
not indicate the expected results. Unfortunately, in the CDI
group, the CD163/CD68 ratio was decreased at day 30
postimplantation, indicating a switch to a proinﬂammatory
and destructive M1 macrophage phenotype. In contrast to
G Aa n dG Pﬁ x e dt i s s u ea sw e l la st ou n t r e a t e ds c a ﬀolds,
we observed a chronic inﬂammation, which was maintained
and increased after the CDI cross-link. One might speculate
that this eﬀect might be caused by incomplete ﬁxation.6 Journal of Biomedicine and Biotechnology
Lumen
(a) (b)
(c)
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(d)
Figure 2: Immunohistochemical DAB staining (brown staining) of decellularized porcine esophagus tissue for collagen III (a), ﬁbronectin
(b), collagen IV (c), and elastin (d) in comparison to natural esophagus (small pictures). The arrow heads mark vessels. Decellularized
esophagus scaﬀolds were shown to maintain native extracellular matrix composition. Original magniﬁcation: x40 (a and d) and x100 (b and
c); bar = 100μm.
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Figure 3:ThecomparisonofremainingDNAcontentindecellular-
ized esophageal tissue with and without DNA digestion (both n =
6). Signiﬁcant diﬀerences between both groups do not exist (P =
n.s.). Native, untreated esophageal tissue served as control (n = 6).
∗∗∗ = P<0.001 versus decellularized esophagus without DNA
digestion group. +++ = P<0.001 versus decellularized esophagus
with DNA digestion group.
Interestingly, other studies described similar eﬀects in CDI-
ﬁxed SIS-ECM tissue [15, 46]. After implantation of CDI-
ﬁxed SIS-ECM, Badylak and colleagues could also observe
a predominant M1 macrophage phenotype, characterized
by chronic inﬂammation at week 16 postimplantation [46].
Furthermore, it is reported that CDI cross-linking caused a
decrease in elasticity and mechanical toughness [47], which
is essential for esophageal function. On the basis of these
data, CDI cannot be considered as an optimal cross-linker
in the present study.
GA is the most common cross-linking agent and often
used in commercially available tissues [15]. Tissue that is
cross-linked with GA exhibits a decreased immunological
reaction and stabilized collagen scaﬀold [41, 48, 49]. We
also observed that the immunological response in GA cross-
linked esophagus scaﬀolds was lower in comparison to
chemically untreated scaﬀolds. At day 30 postimplantation,
the rate of CD163 macrophages was decreased, but the
total number of macrophages (CD68) remained constant
[15, 20, 24, 40]. Interestingly, in contrast to GP, BP, and the
untreated scaﬀold group, CD163/CD68 ratio was decreased
at day 30 postimplantation. This might indicate a switch
to a proinﬂammatory and destructive M1 macrophage
phenotype. An increase of T-lymphocyte inﬁltration could
notbeobserved.However,thesuppressionofimmunological
a c t i o n so fx e n o g r a f t sb yG Ai sn o tc o m p l e t e ;c e l l u l a rt o x i c i t yJournal of Biomedicine and Biotechnology 7
(a) (b) (c)
(d) (e) (f)
Figure 4: Transverse section of subcutaneous untreated (a–c) and GP cross-linked (d–f) implants after 1, 9, and 30 days in vivo.A td a y
1 postimplantation, untreated scaﬀolds (a) displayed a cellular inﬁltration with granulocytes, ﬁbroblasts, and macrophages, whereas in GP
cross-linkedscaﬀolds(d)onlyacellularlayerwasdetectableattheperiphery.Atday9postimplantation,aconsiderableincreaseofinﬁltrating
cells into untreated scaﬀolds (b) was detected as a sign of encapsulation, whereas GP cross-linked (e) scaﬀolds showed a cellular inﬁltration
withgranulocytes,ﬁbroblasts,andmacrophageswithoutsignsofencapsulation.Atday30postimplantation,wholeimplantsoftheuntreated
scaﬀold group (c) were inﬁltrated with granulocytes, ﬁbroblasts, and macrophages, whereas GP cross-linked scaﬀolds (f) showed only an
immaterial cellular inﬁltration. In contrast to GP cross-linked scaﬀolds, untreated scaﬀolds were largely degraded. See Figure 5 for detailed
cellular analysis. Magniﬁcation: ×100, bar = 100μm. HE-staining.
and host immune response (cytotoxic T-cell activation) have
been described [21, 35, 37, 45]. Furthermore, cytotoxicity of
GAcross-linkedbioprosthesesforhostﬁbrocytes,ﬁbroblasts,
and macrophages has been described [50, 51]. In the
present study, we did not observe any cytotoxic eﬀect of
GA cross-linked esophagus scaﬀolds on host ﬁbroblasts or
macrophages compared to the untreated group. However,
the use of GA as a cross-linker to reduce the inﬂammatory
response comprises further disadvantages. Depolymeriza-
tion of GA cross-links as well as calciﬁcation of implants has
been reported [18]. However, in our study, we did not ﬁnd
signs of calciﬁcation and the process of depolymerization
was not investigated. The sum of our data suggests that GA
was not an optimal cross-linker for constructive remodeling
in the present study (e.g., CD68+macrophage inﬁltration),
which corresponds with other disadvantages described in the
literature [35, 37, 50, 51].
A naturally occurring cross-linking agent is GP. It
reacts with collagen amino groups and is approximately
10.000 times less cytotoxic than GA [21, 34, 45]. It forms
stabile cross-linking products, reacts antiphlogistically, pro-
tects against inﬂammatory degradation, and causes faster
tissue regeneration in comparison to GA [30, 39, 52].
An in vitro degradation assay demonstrated that GP-ﬁxed
acellular scaﬀold tissue kept burst pressures equivalent to
GA cross-linked scaﬀold tissue [34]. Furthermore, recent
literature showed that proliferative capacity of inﬁltrated
cells was greater than that after GA cross-linking [31, 34].
In in vivo experiments in dogs, decreased inﬂammation
around implanted GP-ﬁxed acellular arteries was observed
compared to GA-ﬁxed implants; however, the degree of
inﬂammation has not been clearly described [22]. Signs of
calciﬁcation were not detected in GP-ﬁxed tissue [19, 45].
These results correspond to ﬁndings of our studies. In an in
vivo experiment in rats, a minimal macrophage inﬁltration
or localization outside untreated and treated scaﬀolds was
observed at day 30 postimplantation [34]. However, in a
study that compared the host inﬂammatory response to
subcutaneously implanted GP and GA cross-linked acellular
bovine pericardia, the cross-linking with GA caused a
signiﬁcantly increased inﬂammatory response compared to
untreated and GP cross-linked tissue scaﬀolds [21]. We
could show that macrophages were present in untreated and
cross-linked scaﬀolds at day 1 postimplantation. However,
at day 30 postimplantation, pretreatment with GP caused a
signiﬁcant decrease of inﬁltrating macrophages (compared
to untreated scaﬀolds). Moreover, immunohistochemical
staining revealed that pan-macrophage marker CD68 were
signiﬁcantly decreased in GP, similar to the reference scaﬀold
BP (compared to untreated scaﬀolds). In scaﬀolds treated
with GA or CDI, a decrease of CD68 macrophages could8 Journal of Biomedicine and Biotechnology
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Figure 5: HE-staining analysis of the degree of scaﬀold inﬁltration by granulocytes (a), lymphocytes (b), macrophages (c), giant cells (d),
ﬁbroblasts (e), capillaries (f), and collagen ﬁbers (g) after 1, 9, and 30 days. In all implants, an increase of inﬁltration by lymphocytes,
macrophages, giant cells, ﬁbroblasts, capillaries, and collagen ﬁbers could be observed at day 30 compared to day 1 postimplantation.
Furthermore, a decrease of inﬁltrating granulocytes could be observed in all implants at day 30 compared to day 1 postimplantation. Data
were calculated based on the scoring by two blinded pathologists (n = 3 per group and day; one ﬁeld per slide and rat; each 5mm2): 1 = 1–
100 cells; 2 ≥ 100–200 cells; 3 ≥ 200 cells. “-”: untreated scaﬀold; BP: bovine pericardium (St. Jude, USA); GP: genipin; GA: glutaraldehyde;
CDI: carbodiimide. Diﬀerences did not reach the level of signiﬁcance.Journal of Biomedicine and Biotechnology 9
0
10
20
30
40
50
60
70
80
day 9 day 30
C
D
1
6
3
-
p
o
s
i
t
i
v
e
 
c
e
l
l
s
 
(
%
)
U
n
t
r
e
a
t
e
d
B
P
G
P
G
A
C
D
I
U
n
t
r
e
a
t
e
d
B
P
G
P
G
A
C
D
I
∗ ∗ ∗
∗ ∗ ∗ ∗
(a)
0
10
20
30
40
50
60
70
80
day 9 day 30
C
D
6
8
-
p
o
s
i
t
i
v
e
 
c
e
l
l
s
 
(
%
)
U
n
t
r
e
a
t
e
d
B
P
G
P
G
A
C
D
I
U
n
t
r
e
a
t
e
d
B
P
G
P
G
A
C
D
I
∗
∗ ∗
∗
(b)
U
n
t
r
e
a
t
e
d
B
P
G
P
G
A
C
D
I
−100
−50
0
50
100
C
h
a
n
g
e
 
C
D
1
6
3
/
6
8
 
d
a
y
 
9
 
t
o
 
d
a
y
 
3
0
 
(
%
)
(c)
0
10
20
30
40
50
60
70
80
day 9 day 30
h
P
H
-
p
o
s
i
t
i
v
e
 
c
e
l
l
s
 
(
%
)
∗
∗
(d)
Figure 6: Immunohistological analysis of the degree of scaﬀold inﬁltration by CD163 (a), CD68 (b), and hPH-positive ﬁbroblasts (d) after 9
and 30 days, as well as the CD163/CD68 ratio (c). At day 30 postimplantation, a decrease of inﬁltrating CD163-positive macrophages could
beobservedinallimplantscomparedtountreatedscaﬀolds.Furthermore,adecreaseofinﬁltratingCD68+macrophagescouldbeobservedin
the BP group, as well as after cross-linking with GP compared to untreated scaﬀolds at day 30. Untreated and cross-linked scaﬀolds, except
the CDI and GA groups, showed a macrophage M2 phenotype switch at day 30 postimplantation, indicated by a positive CD163/CD68
ratio at day 30 compared to ratio at day 9. All data were represented as ratios of speciﬁc cells/total cells ± SEM. Five microscopic ﬁelds
(magniﬁcation ×1000) of one slide per rat were analyzed (n = 3 per group and day). An average of 75±2.15 total cells per microscopic ﬁeld
was counted to generate the ratio of cells/total cells. All implants were compared by means and conﬁdence interval to the untreated implant.
Diﬀerences were considered as signiﬁcant if conﬁdence intervals do not overlap or by P<0.05, see red line. Untreated: untreated scaﬀold;
BP: bovine pericardium (St. Jude, USA); GP: genipin; GA: glutaraldehyde; CDI: carbodiimide; hPH: hydroxyl-prolyl-hydroxylase. ∗P<0.05,
∗∗ = P<0.01 versus untreated decellularized esophagus tissue.
not be observed and the macrophage inﬁltration remained
unchanged on a high level. One might assume that GP
prevented scaﬀolds from inﬂammation processes in contrast
t oC D Io rG Ao ru n t r e a t e ds c a ﬀolds.
In addition, we calculated the CD163/CD68 ratio to
deﬁne the change in the amount of the proremodeling M2
macrophages over time. At day 30 postimplantation, we
detected an M2 macrophage phenotype switch, which is
known to be associated with constructive remodeling and
tissue repair [20, 22, 23], whereas in GA and CDI cross-
linked scaﬀolds a destructive M1 macrophage phenotype
was detected. Furthermore, GP-ﬁxed scaﬀolds exhibited
a moderate degradation, extremely low lymphocyte inﬁl-
tration and a signiﬁcantly increased ﬁbroblast inﬁltration
compared to untreated scaﬀolds. The presence of prore-
modeling macrophages and ﬁbroblasts (which are some of
the typical cells in the subcutaneous region) cells might be
suggestive of host repair and constructive tissue remodeling
[23, 53]. Furthermore, the inﬁltration, survival, and living
of the tissue-ﬁbroblasts suggested a biocompatibility of GP
scaﬀolds.
5. Conclusion
The present subcutaneous rat model proved to be an
appropriate experimental tool to investigate the inﬂuence
of diﬀerent cross-linking agents on host response (after
implantation of porcine ECM scaﬀolds) and to identify the
best tolerated cross-linking agent. Signs of graft rejection
such as encapsulation or lymphocyte inﬁltration did not
occur in any group. However, diﬀerences in inﬂammatory
p r o c e s s e sa n di n ﬁ l t r a t i o no fc e l l ss u c ha sm a c r o p h a g e s
or ﬁbroblasts could be observed depending on scaﬀold
pretreatmentwithdiﬀerentcrosslinkingagents.Highratesof
proinﬂammatory macrophages were detected in untreated,
CDI, and GA scaﬀolds. This indicated inﬂammatory pro-
cesses resulting in fast scaﬀold degradation and a low rate
of integration of the scaﬀold in the surrounding tissue.
In contrast, scaﬀolds treated with GP were only mildly
inﬁltratedbymacrophages(CD68),similartotheestablished
referencestandardBP.Moreover,inGP,theproinﬂammatory
CD163 macrophage phenotype was signiﬁcantly decreased,
lymphocytes were at the limit of detection, and the rate of
subcutaneous tissue-typical ﬁbroblasts was increased. This10 Journal of Biomedicine and Biotechnology
might suggest that GP was an agent that scaﬀolds prevented
for graft rejection and is eﬃcient to attenuate inﬂammatory
processes. Low rates of macrophages and inﬁltration of
ﬁbroblasts (in the subcutaneous region) in GP scaﬀolds
implyabetterscaﬀoldtoleranceandanimprovedintegration
of esophageal scaﬀolds into their surrounding tissue after
implantation. This suggested the practicability of GP as a
cross-linking agent for implants in clinical application [32].
We consider GP an adequate compromise between the rate
of degradation, inﬂammation, and the inﬁltration by tissue
typical cells.
The results of the present study help to provide a
new piece of the puzzle in the development of esophageal
xenografts. The use of acellular esophagus scaﬀolds could
be an important therapeutic tool in the near future. The
development of a large animal model seems to be the
next step to prove the functionality and host response
(constructiveremodelingprocesses)aftertheimplantationof
segmental GP cross-linked ECM esophagus scaﬀolds in the
esophageal location. If this approach is successful, there is a
wide range of applications possible (e.g., esophagus atresia,
esophageal trauma, long-segment Barrett’s esophagus, etc.)
to increase the quality of life of patients and minimize the
complications in severe esophageal diseases.
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